Back

Enoxaparin versus unfractionated heparin in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention

2 September 2019 (10:05 - 10:55)
Organised by:
Congress Presentation Part of: Revascularisation strategies in ACS Pharmacotherapy ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Luis Graca Santos

Hospital Santo Andre, Leiria (Portugal)

6 More presentations in this session

Presentation thumbnail
Complete versus culprit-vessel only revascularization for patients with acute coronary syndromes and multivessel disease
Doctor J. Ferreira (Coimbra, PT)
Abstract Slides
Presentation thumbnail
Predictive value of the residual SYNTAX score following primary PCI in multivessel patients with MI-related cardiogenic shock - a CULPRIT SHOCK sub-analysis
Doctor O. Barthelemy (Paris, FR)
Abstract Slides
Presentation thumbnail
Five-year impact of immediate invasive strategy on clinical outcomes in patients with non-st segment elevation myocardial infarction: RIDDLE-NSTEMI Study
Doctor A. Milosevic (Belgrade, RS)
Abstract
Presentation thumbnail
Immediate versus delayed revascularization in patients with transient ST-elevation myocardial infarction: 1-year follow-up of the randomized clinical TRANSIENT trial
Miss G. Janssens (Amsterdam, NL)
Abstract Slides
Presentation thumbnail
Optimal revascularization strategy in non-ST-segment elevation myocardial infarction with multivessel coronary artery disease: staged vs. one-time vs. culprit-only revascularization
Associate Professor M. Kim (Gwangju, KR)
Abstract Slides

Access the full session

Session thumbnail
Revascularisation strategies in ACS

The Event

Event poster

ESC Congress 2019

2 September 2019 10:05 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources